MAOB and Parkinson disease: Moreover, ellagic acid has been proven to inhibit type-B monoamine oxidase (MAO-B) [78], thereby protecting rat brains from 6-hydroxydopamine-induced neuroinflammation in a model of Parkinson’s disease [79] and preventing scopolamine- and diazepam-induced cognitive impairments [80].